GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TBX4
|
ENSG00000121075.5 | T-box transcription factor 4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TBX4 | hg19_v2_chr17_+_59529743_59529798 | 0.37 | 2.1e-08 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_+_167453493 | 25.98 |
ENST00000295777.5
ENST00000472747.2 |
SERPINI1
|
serpin peptidase inhibitor, clade I (neuroserpin), member 1 |
chr11_-_5248294 | 21.09 |
ENST00000335295.4
|
HBB
|
hemoglobin, beta |
chr11_+_73358594 | 20.20 |
ENST00000227214.6
ENST00000398494.4 ENST00000543085.1 |
PLEKHB1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr2_-_175869936 | 17.35 |
ENST00000409900.3
|
CHN1
|
chimerin 1 |
chr2_-_175870085 | 16.35 |
ENST00000409156.3
|
CHN1
|
chimerin 1 |
chr14_+_75746781 | 13.57 |
ENST00000555347.1
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr14_+_75745477 | 13.06 |
ENST00000303562.4
ENST00000554617.1 ENST00000554212.1 ENST00000535987.1 ENST00000555242.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr20_+_44657845 | 11.11 |
ENST00000243964.3
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5 |
chr13_-_36429763 | 10.41 |
ENST00000379893.1
|
DCLK1
|
doublecortin-like kinase 1 |
chr5_+_74807886 | 9.76 |
ENST00000514296.1
|
POLK
|
polymerase (DNA directed) kappa |
chr6_+_39760129 | 8.19 |
ENST00000274867.4
|
DAAM2
|
dishevelled associated activator of morphogenesis 2 |
chr7_+_97361218 | 7.56 |
ENST00000319273.5
|
TAC1
|
tachykinin, precursor 1 |
chr3_-_66551397 | 7.40 |
ENST00000383703.3
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1 |
chr2_-_157189180 | 7.01 |
ENST00000539077.1
ENST00000424077.1 ENST00000426264.1 ENST00000339562.4 ENST00000421709.1 |
NR4A2
|
nuclear receptor subfamily 4, group A, member 2 |
chr7_+_97361388 | 6.55 |
ENST00000350485.4
ENST00000346867.4 |
TAC1
|
tachykinin, precursor 1 |
chr1_-_230561475 | 6.35 |
ENST00000391860.1
|
PGBD5
|
piggyBac transposable element derived 5 |
chr3_-_66551351 | 6.04 |
ENST00000273261.3
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1 |
chr11_-_33913708 | 5.92 |
ENST00000257818.2
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
chr1_+_151584544 | 5.75 |
ENST00000458013.2
ENST00000368843.3 |
SNX27
|
sorting nexin family member 27 |
chr18_-_53068911 | 5.22 |
ENST00000537856.3
|
TCF4
|
transcription factor 4 |
chr11_-_33891362 | 5.16 |
ENST00000395833.3
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
chr4_-_186732048 | 5.07 |
ENST00000448662.2
ENST00000439049.1 ENST00000420158.1 ENST00000431808.1 ENST00000319471.9 |
SORBS2
|
sorbin and SH3 domain containing 2 |
chr11_-_133826852 | 4.78 |
ENST00000533871.2
ENST00000321016.8 |
IGSF9B
|
immunoglobulin superfamily, member 9B |
chr2_+_103089756 | 4.76 |
ENST00000295269.4
|
SLC9A4
|
solute carrier family 9, subfamily A (NHE4, cation proton antiporter 4), member 4 |
chr10_-_99531709 | 4.70 |
ENST00000266066.3
|
SFRP5
|
secreted frizzled-related protein 5 |
chr1_+_16062820 | 4.65 |
ENST00000294454.5
|
SLC25A34
|
solute carrier family 25, member 34 |
chr16_+_2588012 | 4.60 |
ENST00000354836.5
ENST00000389224.3 |
PDPK1
|
3-phosphoinositide dependent protein kinase-1 |
chr17_-_8066843 | 4.56 |
ENST00000404970.3
|
VAMP2
|
vesicle-associated membrane protein 2 (synaptobrevin 2) |
chr9_-_75567962 | 4.17 |
ENST00000297785.3
ENST00000376939.1 |
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1 |
chrX_+_56259316 | 4.11 |
ENST00000468660.1
|
KLF8
|
Kruppel-like factor 8 |
chr11_-_129062093 | 4.05 |
ENST00000310343.9
|
ARHGAP32
|
Rho GTPase activating protein 32 |
chr17_-_61988556 | 3.87 |
ENST00000309894.5
ENST00000438387.2 ENST00000346606.6 ENST00000561003.1 ENST00000450719.3 ENST00000259003.10 |
CSHL1
|
chorionic somatomammotropin hormone-like 1 |
chr10_-_75226166 | 3.77 |
ENST00000544628.1
|
PPP3CB
|
protein phosphatase 3, catalytic subunit, beta isozyme |
chr16_+_2587998 | 3.76 |
ENST00000441549.3
ENST00000268673.7 |
PDPK1
|
3-phosphoinositide dependent protein kinase-1 |
chr6_-_13487784 | 3.76 |
ENST00000379287.3
|
GFOD1
|
glucose-fructose oxidoreductase domain containing 1 |
chr17_-_26220366 | 3.62 |
ENST00000460380.2
ENST00000508862.1 ENST00000379102.3 ENST00000582441.1 |
LYRM9
RP1-66C13.4
|
LYR motif containing 9 Uncharacterized protein |
chr3_-_49459865 | 3.40 |
ENST00000427987.1
|
AMT
|
aminomethyltransferase |
chr4_-_102268484 | 3.31 |
ENST00000394853.4
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
chr13_+_115047097 | 3.30 |
ENST00000351487.5
|
UPF3A
|
UPF3 regulator of nonsense transcripts homolog A (yeast) |
chr16_+_2587965 | 3.28 |
ENST00000342085.4
ENST00000566659.1 |
PDPK1
|
3-phosphoinositide dependent protein kinase-1 |
chr17_-_61996160 | 3.28 |
ENST00000458650.2
ENST00000351388.4 ENST00000323322.5 |
GH1
|
growth hormone 1 |
chr7_-_71801980 | 3.25 |
ENST00000329008.5
|
CALN1
|
calneuron 1 |
chr15_-_58357932 | 3.15 |
ENST00000347587.3
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2 |
chr1_+_95582881 | 3.14 |
ENST00000370203.4
ENST00000456991.1 |
TMEM56
|
transmembrane protein 56 |
chr2_+_61108771 | 3.09 |
ENST00000394479.3
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog |
chr1_+_114472481 | 3.02 |
ENST00000369555.2
|
HIPK1
|
homeodomain interacting protein kinase 1 |
chr20_+_44098346 | 3.02 |
ENST00000372676.3
|
WFDC2
|
WAP four-disulfide core domain 2 |
chr17_-_61996192 | 2.93 |
ENST00000392824.4
|
CSHL1
|
chorionic somatomammotropin hormone-like 1 |
chr2_-_25475120 | 2.89 |
ENST00000380746.4
ENST00000402667.1 |
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha |
chr5_+_113697983 | 2.85 |
ENST00000264773.3
|
KCNN2
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 |
chr3_-_49459878 | 2.85 |
ENST00000546031.1
ENST00000458307.2 ENST00000430521.1 |
AMT
|
aminomethyltransferase |
chr15_+_92937144 | 2.80 |
ENST00000539113.1
ENST00000555434.1 |
ST8SIA2
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 |
chrX_+_69642881 | 2.65 |
ENST00000453994.2
ENST00000536730.1 ENST00000538649.1 ENST00000374382.3 |
GDPD2
|
glycerophosphodiester phosphodiesterase domain containing 2 |
chr14_+_21467414 | 2.54 |
ENST00000554422.1
ENST00000298681.4 |
SLC39A2
|
solute carrier family 39 (zinc transporter), member 2 |
chr15_-_83474806 | 2.51 |
ENST00000541889.1
ENST00000334574.8 ENST00000561368.1 |
FSD2
|
fibronectin type III and SPRY domain containing 2 |
chr1_+_27114589 | 2.48 |
ENST00000431541.1
ENST00000449950.2 ENST00000374145.1 |
PIGV
|
phosphatidylinositol glycan anchor biosynthesis, class V |
chr9_+_140032842 | 2.39 |
ENST00000371561.3
ENST00000315048.3 |
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
chr5_-_34043310 | 2.34 |
ENST00000231338.7
|
C1QTNF3
|
C1q and tumor necrosis factor related protein 3 |
chr2_+_61108650 | 2.29 |
ENST00000295025.8
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog |
chr12_-_90024360 | 2.29 |
ENST00000393164.2
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1 |
chr5_+_54320078 | 2.28 |
ENST00000231009.2
|
GZMK
|
granzyme K (granzyme 3; tryptase II) |
chr14_+_78870030 | 2.27 |
ENST00000553631.1
ENST00000554719.1 |
NRXN3
|
neurexin 3 |
chr17_-_61973929 | 2.20 |
ENST00000329882.8
ENST00000453363.3 ENST00000316193.8 |
CSH1
|
chorionic somatomammotropin hormone 1 (placental lactogen) |
chr6_+_79577189 | 2.20 |
ENST00000369940.2
|
IRAK1BP1
|
interleukin-1 receptor-associated kinase 1 binding protein 1 |
chr6_+_32132360 | 2.17 |
ENST00000333845.6
ENST00000395512.1 ENST00000432129.1 |
EGFL8
|
EGF-like-domain, multiple 8 |
chr1_-_11907829 | 2.16 |
ENST00000376480.3
|
NPPA
|
natriuretic peptide A |
chr5_-_60240858 | 2.11 |
ENST00000426742.2
ENST00000265038.5 ENST00000543101.1 ENST00000439176.1 |
ERCC8
|
excision repair cross-complementing rodent repair deficiency, complementation group 8 |
chr17_-_61996136 | 2.09 |
ENST00000342364.4
|
GH1
|
growth hormone 1 |
chr16_-_67965756 | 2.06 |
ENST00000571044.1
ENST00000571605.1 |
CTRL
|
chymotrypsin-like |
chr20_+_44098385 | 2.05 |
ENST00000217425.5
ENST00000339946.3 |
WFDC2
|
WAP four-disulfide core domain 2 |
chr15_+_92937058 | 2.05 |
ENST00000268164.3
|
ST8SIA2
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 |
chr10_+_94833642 | 1.99 |
ENST00000224356.4
ENST00000394139.1 |
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1 |
chr8_+_123793633 | 1.88 |
ENST00000314393.4
|
ZHX2
|
zinc fingers and homeoboxes 2 |
chr5_-_114515734 | 1.77 |
ENST00000514154.1
ENST00000282369.3 |
TRIM36
|
tripartite motif containing 36 |
chr7_+_143013198 | 1.75 |
ENST00000343257.2
|
CLCN1
|
chloride channel, voltage-sensitive 1 |
chr2_-_160473114 | 1.70 |
ENST00000392783.2
|
BAZ2B
|
bromodomain adjacent to zinc finger domain, 2B |
chr12_-_26278030 | 1.69 |
ENST00000242728.4
|
BHLHE41
|
basic helix-loop-helix family, member e41 |
chr11_-_128737259 | 1.67 |
ENST00000440599.2
ENST00000392666.1 ENST00000324036.3 |
KCNJ1
|
potassium inwardly-rectifying channel, subfamily J, member 1 |
chr22_-_42342733 | 1.65 |
ENST00000402420.1
|
CENPM
|
centromere protein M |
chrX_+_16804544 | 1.56 |
ENST00000380122.5
ENST00000398155.4 |
TXLNG
|
taxilin gamma |
chr1_+_27114418 | 1.55 |
ENST00000078527.4
|
PIGV
|
phosphatidylinositol glycan anchor biosynthesis, class V |
chr1_+_114472222 | 1.51 |
ENST00000369558.1
ENST00000369561.4 |
HIPK1
|
homeodomain interacting protein kinase 1 |
chr1_-_1009683 | 1.50 |
ENST00000453464.2
|
RNF223
|
ring finger protein 223 |
chr1_+_172628154 | 1.47 |
ENST00000340030.3
ENST00000367721.2 |
FASLG
|
Fas ligand (TNF superfamily, member 6) |
chr1_-_111148241 | 1.46 |
ENST00000440270.1
|
KCNA2
|
potassium voltage-gated channel, shaker-related subfamily, member 2 |
chr2_+_176972000 | 1.44 |
ENST00000249504.5
|
HOXD11
|
homeobox D11 |
chr10_+_135050908 | 1.41 |
ENST00000325980.9
|
VENTX
|
VENT homeobox |
chr12_+_57853918 | 1.41 |
ENST00000532291.1
ENST00000543426.1 ENST00000228682.2 ENST00000546141.1 |
GLI1
|
GLI family zinc finger 1 |
chr4_-_102268628 | 1.38 |
ENST00000323055.6
ENST00000512215.1 ENST00000394854.3 |
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
chr22_-_41215328 | 1.36 |
ENST00000434185.1
ENST00000435456.2 |
SLC25A17
|
solute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein, 34kDa), member 17 |
chr1_+_114471809 | 1.32 |
ENST00000426820.2
|
HIPK1
|
homeodomain interacting protein kinase 1 |
chr9_-_117692697 | 1.28 |
ENST00000223795.2
|
TNFSF8
|
tumor necrosis factor (ligand) superfamily, member 8 |
chr9_+_71986182 | 1.23 |
ENST00000303068.7
|
FAM189A2
|
family with sequence similarity 189, member A2 |
chr1_+_154377669 | 1.15 |
ENST00000368485.3
ENST00000344086.4 |
IL6R
|
interleukin 6 receptor |
chr8_+_103563792 | 1.11 |
ENST00000285402.3
|
ODF1
|
outer dense fiber of sperm tails 1 |
chr11_-_128737163 | 1.11 |
ENST00000324003.3
ENST00000392665.2 |
KCNJ1
|
potassium inwardly-rectifying channel, subfamily J, member 1 |
chr3_-_52443799 | 1.08 |
ENST00000470173.1
ENST00000296288.5 |
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) |
chr4_-_186456766 | 1.03 |
ENST00000284771.6
|
PDLIM3
|
PDZ and LIM domain 3 |
chr4_+_160188889 | 1.01 |
ENST00000264431.4
|
RAPGEF2
|
Rap guanine nucleotide exchange factor (GEF) 2 |
chr1_-_226076843 | 1.01 |
ENST00000272134.5
|
LEFTY1
|
left-right determination factor 1 |
chr2_-_160472952 | 0.99 |
ENST00000541068.2
ENST00000355831.2 ENST00000343439.5 ENST00000392782.1 |
BAZ2B
|
bromodomain adjacent to zinc finger domain, 2B |
chr2_+_11696464 | 0.97 |
ENST00000234142.5
|
GREB1
|
growth regulation by estrogen in breast cancer 1 |
chrX_-_11445856 | 0.95 |
ENST00000380736.1
|
ARHGAP6
|
Rho GTPase activating protein 6 |
chr1_+_158325684 | 0.93 |
ENST00000368162.2
|
CD1E
|
CD1e molecule |
chr3_-_133748913 | 0.91 |
ENST00000310926.4
|
SLCO2A1
|
solute carrier organic anion transporter family, member 2A1 |
chr4_-_186456652 | 0.78 |
ENST00000284767.5
ENST00000284770.5 |
PDLIM3
|
PDZ and LIM domain 3 |
chr11_+_111749942 | 0.77 |
ENST00000260276.3
|
C11orf1
|
chromosome 11 open reading frame 1 |
chr9_-_74980113 | 0.77 |
ENST00000376962.5
ENST00000376960.4 ENST00000237937.3 |
ZFAND5
|
zinc finger, AN1-type domain 5 |
chr3_+_134514093 | 0.76 |
ENST00000398015.3
|
EPHB1
|
EPH receptor B1 |
chr13_-_52027134 | 0.76 |
ENST00000311234.4
ENST00000425000.1 ENST00000463928.1 ENST00000442263.3 ENST00000398119.2 |
INTS6
|
integrator complex subunit 6 |
chr7_+_27282319 | 0.73 |
ENST00000222761.3
|
EVX1
|
even-skipped homeobox 1 |
chr11_-_6502580 | 0.72 |
ENST00000423813.2
ENST00000396777.3 |
ARFIP2
|
ADP-ribosylation factor interacting protein 2 |
chr11_+_1940786 | 0.67 |
ENST00000278317.6
ENST00000381561.4 ENST00000381548.3 ENST00000360603.3 ENST00000381549.3 |
TNNT3
|
troponin T type 3 (skeletal, fast) |
chr1_+_145507587 | 0.65 |
ENST00000330165.8
ENST00000369307.3 |
RBM8A
|
RNA binding motif protein 8A |
chr20_+_11898507 | 0.65 |
ENST00000378226.2
|
BTBD3
|
BTB (POZ) domain containing 3 |
chr5_-_54281407 | 0.60 |
ENST00000381403.4
|
ESM1
|
endothelial cell-specific molecule 1 |
chr19_-_46526304 | 0.58 |
ENST00000008938.4
|
PGLYRP1
|
peptidoglycan recognition protein 1 |
chr6_-_31080336 | 0.58 |
ENST00000259870.3
|
C6orf15
|
chromosome 6 open reading frame 15 |
chr3_-_197024394 | 0.56 |
ENST00000434148.1
ENST00000412364.2 ENST00000436682.1 ENST00000456699.2 ENST00000392380.2 |
DLG1
|
discs, large homolog 1 (Drosophila) |
chr2_-_85895295 | 0.55 |
ENST00000428225.1
ENST00000519937.2 |
SFTPB
|
surfactant protein B |
chr12_-_7848364 | 0.53 |
ENST00000329913.3
|
GDF3
|
growth differentiation factor 3 |
chrX_+_70443050 | 0.48 |
ENST00000361726.6
|
GJB1
|
gap junction protein, beta 1, 32kDa |
chr1_+_114471972 | 0.47 |
ENST00000369559.4
ENST00000369554.2 |
HIPK1
|
homeodomain interacting protein kinase 1 |
chr4_+_88571429 | 0.41 |
ENST00000339673.6
ENST00000282479.7 |
DMP1
|
dentin matrix acidic phosphoprotein 1 |
chr8_+_73449625 | 0.40 |
ENST00000523207.1
|
KCNB2
|
potassium voltage-gated channel, Shab-related subfamily, member 2 |
chr9_+_136399929 | 0.38 |
ENST00000393060.1
|
ADAMTSL2
|
ADAMTS-like 2 |
chr3_+_120626919 | 0.35 |
ENST00000273666.6
ENST00000471454.1 ENST00000472879.1 ENST00000497029.1 ENST00000492541.1 |
STXBP5L
|
syntaxin binding protein 5-like |
chr1_+_26737292 | 0.33 |
ENST00000254231.4
|
LIN28A
|
lin-28 homolog A (C. elegans) |
chr13_-_103053946 | 0.31 |
ENST00000376131.4
|
FGF14
|
fibroblast growth factor 14 |
chr2_+_62932779 | 0.30 |
ENST00000427809.1
ENST00000405482.1 ENST00000431489.1 |
EHBP1
|
EH domain binding protein 1 |
chr6_+_167536230 | 0.23 |
ENST00000341935.5
ENST00000349984.4 |
CCR6
|
chemokine (C-C motif) receptor 6 |
chr2_+_62933001 | 0.21 |
ENST00000263991.5
ENST00000354487.3 |
EHBP1
|
EH domain binding protein 1 |
chr5_-_74807418 | 0.12 |
ENST00000405807.4
ENST00000261415.7 |
COL4A3BP
|
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein |
chr7_-_150675372 | 0.12 |
ENST00000262186.5
|
KCNH2
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
chr2_+_37458776 | 0.01 |
ENST00000002125.4
ENST00000336237.6 ENST00000431821.1 |
NDUFAF7
|
NADH dehydrogenase (ubiquinone) complex I, assembly factor 7 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 21.1 | GO:0030185 | nitric oxide transport(GO:0030185) |
4.7 | 14.1 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
4.5 | 13.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
3.6 | 29.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
3.1 | 12.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
2.3 | 7.0 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.6 | 4.7 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
1.4 | 4.2 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
1.2 | 6.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.2 | 4.7 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
1.2 | 11.6 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
1.0 | 1.0 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.9 | 31.3 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.7 | 6.3 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.7 | 5.4 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.7 | 2.0 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.7 | 4.6 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.6 | 4.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.5 | 2.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.5 | 2.9 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.5 | 5.8 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
0.5 | 3.8 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.5 | 11.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.5 | 2.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.4 | 11.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.4 | 3.1 | GO:0035799 | ureter maturation(GO:0035799) |
0.4 | 1.1 | GO:0002384 | hepatic immune response(GO:0002384) |
0.4 | 1.5 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.4 | 1.1 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.4 | 2.9 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.4 | 1.4 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.3 | 9.8 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.3 | 5.4 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.3 | 4.8 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.3 | 2.3 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.3 | 20.2 | GO:0007602 | phototransduction(GO:0007602) |
0.3 | 4.8 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.2 | 0.7 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.2 | 26.0 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.2 | 1.8 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 2.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 4.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.2 | 0.6 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
0.2 | 0.5 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 4.2 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 2.3 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.1 | 2.5 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 2.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.1 | 1.7 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.6 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
0.1 | 8.7 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.1 | 1.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.9 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 2.8 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.2 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.1 | 0.4 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.1 | 1.8 | GO:0007507 | heart development(GO:0007507) |
0.1 | 1.7 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.6 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.1 | 0.9 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.4 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.0 | 0.1 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.0 | 0.1 | GO:1902303 | regulation of heart rate by hormone(GO:0003064) negative regulation of potassium ion export(GO:1902303) |
0.0 | 0.3 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.0 | 0.9 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.0 | 0.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 2.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 1.4 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.0 | 1.6 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.0 | 4.0 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 4.7 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.0 | 6.2 | GO:0048232 | spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
0.0 | 0.4 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 3.7 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
0.0 | 1.9 | GO:0045665 | negative regulation of neuron differentiation(GO:0045665) |
0.0 | 0.4 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.0 | 4.0 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 21.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
3.3 | 26.6 | GO:0035976 | AP1 complex(GO:0035976) |
1.8 | 5.4 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
1.1 | 4.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.9 | 8.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.8 | 5.8 | GO:0071203 | WASH complex(GO:0071203) |
0.8 | 4.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.4 | 5.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 4.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.3 | 1.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 2.4 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.2 | 2.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 35.7 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 11.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 2.9 | GO:0001741 | XY body(GO:0001741) |
0.2 | 2.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 1.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 4.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.8 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.6 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.1 | 4.1 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.1 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.1 | 2.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.6 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 9.0 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 13.4 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 2.2 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 3.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 2.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.0 | 14.0 | GO:0030424 | axon(GO:0030424) |
0.0 | 1.4 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 4.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.7 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 5.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.5 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 3.5 | GO:0016605 | PML body(GO:0016605) |
0.0 | 2.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 1.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 1.8 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 1.5 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 1.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 5.1 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 1.7 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.0 | 2.6 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 6.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.6 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
3.5 | 21.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
1.8 | 5.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
1.6 | 6.2 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
1.3 | 5.1 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
1.0 | 11.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.0 | 4.0 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.8 | 8.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.8 | 4.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.7 | 4.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.7 | 33.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.7 | 39.4 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.7 | 2.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.6 | 2.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.5 | 2.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.5 | 4.8 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.5 | 2.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 16.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.4 | 5.2 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.4 | 1.1 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.4 | 7.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 9.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 3.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.3 | 2.4 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.2 | 24.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 5.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 5.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 4.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 1.0 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.2 | 0.6 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.2 | 0.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 2.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.2 | 0.7 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 0.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 4.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 2.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 5.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.9 | GO:0030882 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.1 | 3.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 1.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 1.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 2.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.4 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 8.2 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 2.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 2.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.6 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.1 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) coenzyme transporter activity(GO:0051185) |
0.0 | 0.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 2.1 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.0 | 0.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 1.9 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 1.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 1.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 1.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 3.1 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 5.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 15.7 | GO:0004871 | signal transducer activity(GO:0004871) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 26.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.5 | 33.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.4 | 11.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 13.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 9.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 23.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 5.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 4.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 4.0 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 23.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 4.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 5.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 2.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 1.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 2.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 1.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 2.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 26.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.5 | 4.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.4 | 11.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.3 | 7.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 4.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 4.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 34.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 2.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 4.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 2.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 21.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 7.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 15.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 5.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 2.8 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 1.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 14.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 4.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 2.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 5.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 5.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 1.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 4.9 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 2.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 4.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |